| April 22, 2024 |
The joint project of The Sixth People's Hospital of Shanghai Jiao Tong University School of Medicine and Hong Kong Baptist University...The joint project of The Sixth People's Hospital of Shanghai Jiao Tong University School of Medicine and Hong Kong Baptist University |
| March 19, 2024 |
Dr. Han Gang from Tianjin Medical University was invited for an exchange visit to TMBJ...On March 19th, Dr. Han Gang from Tianjin Medical University visited TMBJ and delivered an inspiring lecture titled "Research on Targeted Therapy Research for Muscle Diseases." |
| February 22, 2024 |
Nucleic acid aptamer treatment for X-linked hypophosphatemic rickets receives US FDA Orphan Drug Designation and Pediatric Rare Disease Designation...The long-acting sclerostin-loop3 nucleic acid aptamer Apc001OA for the treatment of XLH, developed by Prof. ZHANG Ge [Law Sau Fai Institute for Advancing Translational Medicine in Bone&Joint Diseases, Hong Kong Baptist University (HKBU)], Prof. ZHANG Zhenlin (Osteoporosis and Bone Diseases, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine) and Aptacure Therapeutics Ltd., was granted Orphan Drug Designation (DRU-2023-9894) and Pediatric Rare Disease Designation (RPD-2023-780) by the U.S. FDA on 22nd February, 2024, respectively. |
| June 05, 2023 |
The Aptamer Long-lasting Modification Strategy project by TMBJ has won the second prize at the 9th Hong Kong University Student Innovation and Entrepreneurship Competition....The Hong Kong New Generation Cultural Association held the 9th Hong Kong University Student Innovation and Entrepreneurship Competition on June 2, 2023. The competition covered various categories, including life science. A total of 385 projects from 21 tertiary institutions participated in this edition of the competition. The team from the Law Sau Fai Institute for Advancing Translational Medicine in Bone & Joint Diseases (TMBJ) Hong Kong Baptist University, won the second prize in the life science category (ranking second) after passing the initial screening and second round of defense. |
| June 05, 2023 |
The project ‘Sclerostin Aptamer for treatment of osteogenesis imperfecta’ won the third prize at the 9th Hong Kong University Student Innovation and Entrepreneurship Competition...The project ‘Sclerostin Aptamer for treatment of osteogenesis imperfecta’ won the third prize at the 9th Hong Kong University Student Innovation and Entrepreneurship Competition |
| April 18, 2023 |
The Project of “Development Of Small-molecule Inhibitors Targeting Sclerostin Loop3 For Reversing Established Osteoporosis” Was Funded By Innovation And Technology Fund...Professor Zhang Ge, together with Professor Lei Jinping from Sun Yat-sen University, applied for the Guangdong-Hong Kong Technology Cooperation Funding Scheme (TCFS) titled "Development of Small-molecule Inhibitors Targeting Sclerostin Loop3 for Reversing Established Osteoporosis". |
| December 28, 2022 |
Apc001 [Jointly Developed by Law Sau Fai Institute for Advancing Translational Medicine in Bone&Joint Diseases (TMBJ), HKBU and Aptacure] was Exhibited at BIOHK 2022....Apc001 [Jointly Developed by Law Sau Fai Institute for Advancing Translational Medicine in Bone&Joint Diseases (TMBJ), HKBU and Aptacure] was Exhibited at BIOHK 2022. |
| December 11, 2022 |
Apc001 from the Law Sau Fai Institute for Advancing Translational Medicine in Bone & Joint Disease has been recognized as representative achievement in the field of medical and health sciences for the 25th anniversary of Hong Kong’s return to the Motherland...Apc001 from the Law Sau Fai Institute for Advancing Translational Medicine in Bone & Joint Disease has been recognized as representative achievement in the field of medical and health sciences for the 25th anniversary of Hong Kong’s return to the Motherland |
| December 05, 2022 |
Apc001, developed by the joint research team of TMBJ, participated in the "Asian Healthcare Summit Forum" exhibition...Apc001, developed by the joint research team of TMBJ, participated in the "Asian Healthcare Summit Forum" exhibition |
| December 05, 2022 |
Apc001OA from the Law Sau Fai Institute for Advancing Translational Medicine in Bone & Joint Disease was granted as Hong Kong First Rare Pediatric Designation for the Treatment of Osteogenesis Imperfecta...Apc001OA from the Law Sau Fai Institute for Advancing Translational Medicine in Bone & Joint Disease was granted as Hong Kong First Rare Pediatric Designation for the Treatment of Osteogenesis Imperfecta |
| November 02, 2022 |
Scientist from the Institute of Bone and Joint Disease Translational Medicine at Hong Kong Baptist University received the Best Poster Award in the BlueSky project...Scientist from the Institute of Bone and Joint Disease Translational Medicine at Hong Kong Baptist University received the Best Poster Award in the BlueSky project |
| November 02, 2022 |
Institute for Advancing Translational Medicine in Bone & Joint Diseases (TMBJ), in collaboration with Aptacure, showcased Apc001 at the "Innovation and Technology Carnival 2022"...Institute for Advancing Translational Medicine in Bone & Joint Diseases (TMBJ), in collaboration with Aptacure, showcased Apc001 at the "Innovation and Technology Carnival 2022" |
| October 31, 2022 |
Joint Publication on Long-lasting Therapeutic Nucleic Acid Aptamer Targeting Strategies by Institute for Advancing Translational Medicine in Bone & Joint Diseases (TMBJ) and The Chinese University of Hong Kong...Joint Publication on Long-lasting Therapeutic Nucleic Acid Aptamer Targeting Strategies by Institute for Advancing Translational Medicine in Bone & Joint Diseases (TMBJ) and The Chinese University of Hong Kong |
| September 19, 2022 |
Imperial College London (School of Medicine) and Hong Kong Baptist University discovered a close association between mutations in specific regions of the sclerostin and cardiovascular abnormalities...Imperial College London (School of Medicine) and Hong Kong Baptist University discovered a close association between mutations in specific regions of the sclerostin and cardiovascular abnormalities |
| August 01, 2022 |
Hong Kong Baptist University Leads University-company Collaborative Innovation in the Field of New Strategies for Osteogenic Treatment: From Molecular Target to Aptamer Drug Discovery towards U.S. FDA Orphan Drug Designation...Hong Kong Baptist University Leads University-company Collaborative Innovation in the Field of New Strategies for Osteogenic Treatment: From Molecular Target to Aptamer Drug Discovery towards U.S. FDA Orphan Drug Designation |
| May 25, 2022 |
Professor Aiping Lyu from the Law Sau Fai Institute For Advancing Translational Medicine In Bone&Joint Diseases of Hong Kong Baptist University was elected as a member of The Academy of Europe...Professor Aiping Lyu from the Law Sau Fai Institute For Advancing Translational Medicine In Bone&Joint Diseases of Hong Kong Baptist University was elected as a member of The Academy of Europe |
| May 19, 2022 |
Professor Zhang Ge’s team from the Law Institute for Translational Medicine of Bone and Joint Diseases of Hong Kong Baptist University, research team from the Chinese University of Hong Kong and Shanghai Jiao Tong University jointly published a systematic review of sclerostin inhibitors drug discovery...Professor Zhang Ge’s team from the Law Institute for Translational Medicine of Bone and Joint Diseases of Hong Kong Baptist University, research team from the Chinese University of Hong Kong and Shanghai Jiao Tong University jointly published a systematic review of sclerostin inhibitors drug discovery |
| May 31, 2020 |
The team led by Zhang Baoting and scientists from the Institute of Translational Medicine in Bone & Joint Diseases (TMBJ) at Hong Kong Baptist University, under Luo Shouhui, have proposed a new strategy for virtual screening of miRNA targets....The team led by Zhang Baoting and scientists from the Institute of Translational Medicine in Bone & Joint Diseases (TMBJ) at Hong Kong Baptist University, under Luo Shouhui, have proposed a new strategy for virtual screening of miRNA targets. |
| October 24, 2019 |
TMBJ members were invited to attend the 2019 RNAi China Conference...TMBJ members were invited to attend the 2019 RNAi China Conference |
| October 24, 2019 |
Prof. Zhang Ge, the Deputy Director of TMBJ was invited to attend the 10th national conference on osteoporosis and bone mineral salt diseases of Chinese medical association....Prof. Zhang Ge, the Deputy Director of TMBJ was invited to attend the 10th national conference on osteoporosis and bone mineral salt diseases of Chinese medical association. |
